Wang Ligen

Spécialisation: Clinical oncologist
40 années d'expérience
Espace de travail: Malaisie, Kuala Lumpur, St. Stamford Modern Cancer Hospital Guangzhou
- As a specialist at St. Stamford Modern Cancer Hospital Guangzhou, Prof. Wang Ligen is Director of the International Medical Exchange Center and Chief Physician at Modern Cancer Hospital Guangzhou.
- He is described as one of China’s first certified physicians for operating large-scale radiotherapy equipment—Linear Accelerator (LA)—and has over 40 years of clinical experience.
- For more than 30 years, he has worked in clinical oncology and research in 3A hospitals, and he serves as a Visiting Specialist for Southeast Asia lectures and consultations.
Prof. Wang Ligen is a specialist at St. Stamford Modern Cancer Hospital Guangzhou, serving as Director of the International Medical Exchange Center and Chief Physician. He focuses on clinical oncology and radiation oncology, including operation of large-scale radiotherapy equipment (Linear Accelerator, LA). With over 40 years of clinical experience and more than 30 years in oncology research, he also supports Southeast Asia consultations.

Services du médecin

Où en sommes-nous ?

1 de 3

Les détails sur ce médecin sont exhaustifs et clairs

Fortement en désaccord

Fortement d’accord

Qualifications

With Linear Accelerator (LA) operating experience described as among China’s first certified physicians, Wang Ligen has been part of the radiotherapy journey from early development to broader standardization. As a specialist at St. Stamford Modern Cancer Hospital Guangzhou, he works in radiation oncology and clinical oncology and leads international coordination through the International Medical Exchange Center. He is also listed as Chief Physician at Modern Cancer Hospital Guangzhou and serves as a Visiting Specialist for Southeast Asia lectures and consultations.

His clinical background is framed around more than 40 years of experience, including over 30 years engaged in clinical oncology and research in 3A hospitals. The hospital context also links his oncology practice to cancers such as pancreatic cancer and colon cancer, with radiation therapy and radiation therapy for colorectal/bowel disease described among his treated areas.

Education

Doctorate — Shanghai Medical College, Fudan University (year not stated).

Work experience

Director, International Medical Exchange Center — Chief Physician, Modern Cancer Hospital Guangzhou (dates not stated).
Visiting Specialist for Southeast Asia Lectures and Consultations, Modern Cancer Hospital Guangzhou (dates not stated).

Clinical focus and techniques

Wang Ligen’s work is centered on radiation oncology within clinical oncology care, including hands-on operation of large-scale radiotherapy equipment.

Operating large-scale radiotherapy equipment: Linear Accelerator (LA).
Radiotherapy for pancreatic cancer.
Radiation therapy for bowel cancer / radiation therapy for colorectal cancer.

Professional societies and certifications

Described as one of China’s first certified physicians for operating large-scale radiotherapy equipment (Linear Accelerator, LA).

Academic output

His profile emphasizes long-term clinical oncology and research involvement in 3A hospitals for more than 30 years, alongside international medical exchange leadership.

Courses and advanced training

Visiting Specialist for Southeast Asia lectures and consultations, Modern Cancer Hospital Guangzhou.

Awards and recognition

Recognized in his profile as one of China’s first certified physicians for operating large-scale radiotherapy equipment (Linear Accelerator, LA).

For international patients, the hospital’s service model supports remote appointment steps and coordinated in-person visits, including dedicated staff assistance from consultation to follow-up. While specific languages are not listed for Wang Ligen, his role as a Visiting Specialist for Southeast Asia lectures and consultations is positioned for cross-border patient access. Patients commonly seek his oncology consultation for cancers including pancreatic cancer and colon/colorectal cancer.